Correlation Between SAB Biotherapeutics and Black Diamond
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Black Diamond Therapeutics, you can compare the effects of market volatilities on SAB Biotherapeutics and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Black Diamond.
Diversification Opportunities for SAB Biotherapeutics and Black Diamond
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Black is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Black Diamond go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Black Diamond
Given the investment horizon of 90 days SAB Biotherapeutics is expected to under-perform the Black Diamond. But the stock apears to be less risky and, when comparing its historical volatility, SAB Biotherapeutics is 1.58 times less risky than Black Diamond. The stock trades about 0.0 of its potential returns per unit of risk. The Black Diamond Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 186.00 in Black Diamond Therapeutics on August 24, 2024 and sell it today you would earn a total of 68.00 from holding Black Diamond Therapeutics or generate 36.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Black Diamond Therapeutics
Performance |
| Timeline |
| SAB Biotherapeutics |
| Black Diamond Therap |
SAB Biotherapeutics and Black Diamond Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Black Diamond
The main advantage of trading using opposite SAB Biotherapeutics and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
| Black Diamond vs. Lyra Therapeutics | Black Diamond vs. Hookipa Pharma | Black Diamond vs. Cingulate Warrants | Black Diamond vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |